Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Considering a patients DPD variant status may optimize 5-FU dosing and mitigate adverse effects during cancer treatment [113]
3.9% (obesity) Pregnancy loss higher in all groups with metabolic risk (2329%) Live birth rate: 59% (GLP-1 RA group) Conclusion: Reassuring data with no signal for increased congenital malformations
Its important to still enjoy food while also benefitting from the positive effects of the medication
Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus
10.1023/A:1015320423577 11
Solutions: Use a higher concentration with smaller reconstitution volume, which does not actually solve the stability issue since the same amount of time passes Start at a higher dose point if your protocol allows (only if you have already titrated up with a smaller vial) Consider aliquoting into smaller sterile vials and freezing portions for later use (reduces contamination risk to the main vial) Share the reconstitution timing with your dosing schedule, only reconstituting when you are at a dose where you will use the vial within 28-60 days For researchers at 10 mg or 15 mg weekly, the 60 mg vial is perfect
